Recommended OTC Dosages for Vitamin D, B12, and Iron
For healthy adults, take 1500-2000 IU of vitamin D3 daily, 1000 mcg of vitamin B12 (cyanocobalamin) daily, and 65 mg of elemental iron (one 324 mg ferrous sulfate tablet) daily if iron deficiency is present.
Vitamin D3 Supplementation
The Endocrine Society guidelines provide the most comprehensive framework for vitamin D dosing 1:
Age-Based Recommendations:
- Adults 19-50 years: Minimum 600 IU/day, but 1500-2000 IU/day is needed to consistently maintain blood levels above 30 ng/mL 1
- Adults 50-70 years: Minimum 600 IU/day, but 1500-2000 IU/day recommended for optimal levels 1
- Adults >70 years: Minimum 800 IU/day, but 1500-2000 IU/day recommended 1
Key Considerations:
- The standard 600-800 IU doses meet basic bone health requirements but are insufficient for optimal vitamin D status (>30 ng/mL) 1
- Vitamin D3 (cholecalciferol) is preferred over D2 for OTC supplementation, as it maintains levels longer with intermittent dosing 2
- The tolerable upper limit is 4000 IU/day for adults over 8 years without medical supervision 1
- Higher doses (2-3x standard) are needed for obese individuals or those on certain medications (anticonvulsants, glucocorticoids) 1
Safety Profile:
Toxicity occurs only with daily intake >100,000 IU or blood levels >100 ng/mL 2. The 1500-2000 IU/day dose has been studied for years without significant safety concerns 1.
Vitamin B12 (Cyanocobalamin) Supplementation
The FDA-approved OTC dose is 1000 mcg (1 mg) daily 3.
Evidence-Based Rationale:
- Adults over 50 should consume B12 in crystalline (supplemental) form rather than relying on food sources, as atrophic gastritis impairs absorption of protein-bound B12 4
- Research demonstrates that 500-1000 mcg daily effectively reverses biochemical B12 deficiency in older adults 4, 5
- The dose needed to normalize deficiency is >200 times the RDA (which is only 2.4 mcg/day) 5
- Lower doses (2.5-250 mcg) produce minimal improvements in deficiency markers 5
Clinical Context:
The 1000 mcg daily dose is appropriate for general supplementation and prevention. This high dose compensates for variable absorption efficiency and ensures adequate uptake even in individuals with mild malabsorption.
Iron (Ferrous Sulfate) Supplementation
Standard OTC dose: 324 mg ferrous sulfate tablet = 65 mg elemental iron daily 6.
Important Guidance from AGA Guidelines 7:
When to Use Oral Iron:
- First-line treatment for iron deficiency anemia when absorption is intact
- Ferrous sulfate is preferred as the least expensive formulation with no advantage of other oral forms 7
Dosing Strategy:
- Once daily dosing is maximum; more frequent dosing doesn't improve absorption 7
- Every-other-day dosing may be better tolerated with similar absorption rates 7
- Add vitamin C to improve absorption 7
When to Switch to IV Iron:
- Oral iron intolerance
- Ferritin levels don't improve after oral trial
- Conditions with impaired absorption (inflammatory bowel disease, post-bariatric surgery, celiac disease) 7
Practical Considerations:
One 324 mg ferrous sulfate tablet provides 362% of the RDI for adults 6. This dose is appropriate for treating deficiency but may be excessive for maintenance once stores are replenished. The every-other-day strategy reduces gastrointestinal side effects while maintaining efficacy.
Common Pitfalls to Avoid:
- Vitamin D: Don't rely on the minimal RDA (600-800 IU); these doses rarely achieve optimal blood levels
- B12: Don't assume dietary intake is sufficient in adults >50 years; crystalline supplementation is necessary
- Iron: Don't take multiple doses per day thinking it improves absorption—it only increases side effects
- Iron: Don't continue oral iron indefinitely if ferritin doesn't improve; consider IV formulation
Monitoring Recommendations:
- Vitamin D: Consider checking 25(OH)D levels if supplementing to confirm achievement of >30 ng/mL target
- B12: Baseline and follow-up testing may be warranted in older adults or those with absorption issues
- Iron: Monitor ferritin levels to assess response; persistent deficiency despite oral supplementation warrants investigation for malabsorption or ongoing blood loss